IPP Bureau
Wockhardt PAT at Rs 33.53 cr. in Q2FY22
By IPP Bureau - November 09, 2021
The Board of Directors of Wockhardt have approved the unaudited consolidated financial results for the period ended September 30, 2021.
Clarivate and BARDA collaborate to identify therapeutics that can be repurposed for medical countermeasures
By IPP Bureau - November 09, 2021
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively
By IPP Bureau - November 09, 2021
Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma
EVA Pharma to open vaccine manufacturing facility in Cairo
By IPP Bureau - November 09, 2021
The new facility will provide an important boost to vaccine capacity in Africa
Sanofi to invest up to US $ 60 million in Gyroscope
By IPP Bureau - November 09, 2021
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
First clinical use of Lucent 3D Lumber successful
By IPP Bureau - November 09, 2021
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore
By IPP Bureau - November 09, 2021
The company has operations in North America, Asia, and Europe,
Pfizer’s Covid-19 drug a potential game changer
By IPP Bureau - November 08, 2021
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Divis Labs PAT at Rs 606.46 cr. in Q2FY22
By IPP Bureau - November 08, 2021
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Lupin launches fenofibrate in the US
By IPP Bureau - November 08, 2021
The drug helps in managing cholesterol
Govt places orders for one crore doses of ZyCoV-D
By IPP Bureau - November 08, 2021
It is the world’s first DNA-based Covid vaccine
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
By IPP Bureau - November 08, 2021
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
UK authorises first Covid-19 pill
By IPP Bureau - November 05, 2021
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Novavax files emergency use listing with WHO for Covid-19 vaccine
By IPP Bureau - November 05, 2021
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
CorporateServe launches PharmaSoft 2.0
By IPP Bureau - November 05, 2021
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
